Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better
Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats.
- Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better
Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats.
- Study: Chromium Picolinate Helps Muscles Use Blood Sugar - Prompts Insulin to Work Better
Study published in February's Journal of Nutrition reports that daily use of chromium picolinate enhanced muscle sensitivity to insulin in obese, insulin-resistant rats.
- New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function
Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations.
- New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function
Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations.
- New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function
Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations.
- New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function
Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations.
- New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function
Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations.
- Herbal Remedy Could Help Sufferers of Type 2 Diabetes
British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure.
- Herbal Remedy Could Help Sufferers of Type 2 Diabetes
British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure.
- Herbal Remedy Could Help Sufferers of Type 2 Diabetes
British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure.
- Herbal Remedy Could Help Sufferers of Type 2 Diabetes
British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure.
- Herbal Remedy Could Help Sufferers of Type 2 Diabetes
British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure.
- Herbal Remedy Could Help Sufferers of Type 2 Diabetes
British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure.
- Herbal Remedy Could Help Sufferers of Type 2 Diabetes
British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure.
- Herbal Remedy Could Help Sufferers of Type 2 Diabetes
British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure.
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- Zsweet(TM), 100% All Natural, Zero Calorie Sweetener, Shows No Impact on Blood Sugar
Company has announced completion of a clinical study to determine the ultra-low glycemic response in humans on Zsweet(TM), patent-pending sweetener. Study indicated that consuming 15 grams (3 tsp.) of Zsweet(TM), on average, did not raise or lower blood glucose levels in healthy individuals
- New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes
Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study.
- New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes
Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study.
- New Clinical Trial Demonstrates Diachrome(R) Safely Lowers Blood Sugar Levels in People with Type 2 Diabetes
Study, presented at the American Diabetes Association (ADA) 66th Annual Scientific Sessions, describes an open-label extension phase to the previously reported 90-day, randomized, double-blind, placebo-controlled, multi-center study that evaluated 368 subjects taking daily Diachrome supplementation, (which showed a 0.53% average drop in HbA1c), noting a further average decrease of 0.96% HbA1c in the longer term study.
- Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions
Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome.
- Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions
Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome.
- Clinical study on Cargill’s Barliv(TM) Barley Beta-Glucan to be presented at American Diabetes Association’s 66th Scientific Sessions
Double blind study results, presented at the American Diabetes Association’s 66th Scientific Sessions, indicate that adding barley beta-glucan to the diet can significantly improve multiple CVD risk markers, and after-meal metabolism among individuals with the metabolic syndrome.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- Compound in dairy products targets diabetes
According to a researcher at Penn State, fatty acids commonly found in dairy products, known as conjugated linoleic acids (CLA), ave successfully treated diabetes in mice and have also shown promising results in human trials.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study Published in Diabetes Care Shows that Supplementation with Chromium Picolinate Significantly Improves Glycemic Control and Attenuates Weight Gain
Results from a new study, conducted by researchers at Pennington Biomedical Research Center (PBRC) and the University of Vermont College of Medicine, and published in the August issue of Diabetes Care, in patients with type 2 diabetes demonstrate that daily supplementation with 1000 mcg of chromium as chromium picolinate, in combination with a common oral anti-diabetic medication, improves insulin sensitivity and glucose control better than the oral anti-diabetic agent alone.
- New Study Shows Cinnamon Extract Provides Antioxidant Support for People with Impaired Fasting Blood Sugar
Data from placebo-controlled, double blind study, presented at the 47th American College of Nutrition annual meeting indicates that proprietary cinnamon extract may provide protective antioxidant effects in reducing oxidative stress associated with the metabolic syndrome which is associated with early signs of diabetes and cardiovascular diseases.
- New Study Shows Cinnamon Extract Provides Antioxidant Support for People with Impaired Fasting Blood Sugar
Data from placebo-controlled, double blind study, presented at the 47th American College of Nutrition annual meeting indicates that proprietary cinnamon extract may provide protective antioxidant effects in reducing oxidative stress associated with the metabolic syndrome which is associated with early signs of diabetes and cardiovascular diseases.
- New Study Shows Cinnamon Extract Provides Antioxidant Support for People with Impaired Fasting Blood Sugar
Data from placebo-controlled, double blind study, presented at the 47th American College of Nutrition annual meeting indicates that proprietary cinnamon extract may provide protective antioxidant effects in reducing oxidative stress associated with the metabolic syndrome which is associated with early signs of diabetes and cardiovascular diseases.
- Silymarin may help sugar-control in people with type II diabetes
Research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels.
- Silymarin may help sugar-control in people with type II diabetes
Research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels.
- Silymarin may help sugar-control in people with type II diabetes
Research published this week in Phytotherapy Research shows that this extract can help people significantly lower the amount of sugar bound to haemoglobin in blood, as well as reducing fasting blood sugar levels.
- New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes
results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.
- New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes
results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.
- New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes
results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.
- New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes
results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.
- New Published Research Affirms the Benefits of Diachrome(R) for Improving Blood Sugar in People with Type 2 Diabetes
results of a recent placebo controlled, double-blind, randomized, single center study, published in the December issue of Diabetes Technology and Therapeutics, indicate that Diachrome(R), a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.
- Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management
A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes.
- Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management
A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes.
- Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management
A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes.
- Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management
A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes.
- Review Indicates That Chromium Picolinate Shows Clinical Benefits in Diabetes Management
A review of 15 clinical studies of people with diabetes, published in Diabetes Technology & Therapeutics, confirms that chromium picolinate is effective in improving glycemic control and normalizing lipid levels in people with type 2 diabetes.
- Landmark Study Shows Diachrome(R) Significantly Improves Blood Sugar Control in People with Type 2 Diabetes
Company announces new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome(R) significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
- Landmark Study Shows Diachrome(R) Significantly Improves Blood Sugar Control in People with Type 2 Diabetes
Company announces new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome(R) significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
- Landmark Study Shows Diachrome(R) Significantly Improves Blood Sugar Control in People with Type 2 Diabetes
Company announces new published results from a 447 subject, randomized, double-blind, placebo-controlled clinical study that showed Diachrome(R) significantly improved glycemic control in patients with poorly controlled blood sugar levels who were being treated with oral anti-diabetic medication (OADs).
- Research Indicates That Low Glycemic Diet Works Better Than Low-fat Diet For High Insulin Secretors
Study published in the Journal of the American Medical Association (JAMA) May 16, 2007 , involving 73 obese adults, aged between 18 to 35 years, at the Children’s Hospital Boston, showed greater weight loss among participants who followed a low glycemic load (GL) diet over a low fat diet.
- Research Indicates That Low Glycemic Diet Works Better Than Low-fat Diet For High Insulin Secretors
Study published in the Journal of the American Medical Association (JAMA) May 16, 2007 , involving 73 obese adults, aged between 18 to 35 years, at the Children’s Hospital Boston, showed greater weight loss among participants who followed a low glycemic load (GL) diet over a low fat diet.
- Research Indicates That Low Glycemic Diet Works Better Than Low-fat Diet For High Insulin Secretors
Study published in the Journal of the American Medical Association (JAMA) May 16, 2007 , involving 73 obese adults, aged between 18 to 35 years, at the Children’s Hospital Boston, showed greater weight loss among participants who followed a low glycemic load (GL) diet over a low fat diet.
- New Study Links Skeleton with Obesity and Diabetes
A study in the journal Cell, “Endocrine Regulation of Energy Metabolism by the Skeleton”, links the vitamin K-dependent protein Osteocalcin to insulin activity and the reduction of obesity and diabetes in mice.
- New Study Links Skeleton with Obesity and Diabetes
A study in the journal Cell, “Endocrine Regulation of Energy Metabolism by the Skeleton”, links the vitamin K-dependent protein Osteocalcin to insulin activity and the reduction of obesity and diabetes in mice.
- New Study Links Skeleton with Obesity and Diabetes
A study in the journal Cell, “Endocrine Regulation of Energy Metabolism by the Skeleton”, links the vitamin K-dependent protein Osteocalcin to insulin activity and the reduction of obesity and diabetes in mice.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
SARASOTA, FL, June 29, 2006 – A water-soluble, cinnamon extract has been shown to reduce fasting blood sugar levels in patients with type 2 diabetes, according to a new study from the University of Hannover in Hannover, Germany published in a recent issue of the European Journal of Clinical Investigation. This was the first study evaluating the effect of a water-soluble cinnamon extract on glycemic control and the lipid profile of Western patients with type 2 diabetes. The results further add to a growing body of clinical evidence demonstrating supplementation with a water-soluble cinnamon extract may play an important role in managing blood sugar levels and improving insulin function.
The placebo-controlled, double-blind study was designed to determine the effect of a water-soluble cinnamon extract on glycemic control and cardiovascular risk factors in patients with type 2 diabetes. A total of 79 patients with type 2 diabetes not on insulin therapy but treated with oral medication or diet therapy were randomly assigned to take either a cinnamon extract or placebo capsule three times daily for four months. The cinnamon capsule contained 112 mg of water-soluble extract, an equivalent of one gram of cinnamon powder. The cinnamon extract group experienced a significant reduction in fasting plasma glucose levels (10.3%) versus the placebo group (3.4%). Changes in HbA1c and lipid profiles were not statistically significant.
In the U.S., Cinnulin PF is the only water-soluble cinnamon extract ingredient standardized for the recognized active component in cinnamon, double-linked Type-A Polymers. Despite USDA studies showing the health benefits of cinnamon, researchers note that when consumed consistently or in high doses, whole cinnamon and fat-soluble extracts may be toxic. Cinnulin PF retains the active components without the potentially harmful compounds, making it completely safe for everyday use.
"This study, together with a recent clinical trial utilizing Cinnulin PF, provides compelling evidence for the beneficial effects of a water-soluble cinnamon extract on blood sugar levels," stated Tim Romero, executive vice president, Integrity Nutraceuticals International, marketer of Cinnulin PF. "We are excited to see in the coming months results of studies underway that further substantiate the efficacy and safety of Cinnulin PF."
Integrity Nutraceuticals International, founded in 1999, is a global raw material supplier of bulk nutraceuticals. They import only the finest materials from China and India and specialize in custom formulations. Integrity’s focus is to introduce innovative ingredients into the market based on science and research. Their inventory consists of a wide variety of products including: amino acids, creatine, sports enhancing supplements, joint and heath care items, specialty items and herbs. Integrity’s products are verified analytically in their state-of-the-art in-house laboratory equipped with HPLC, FT-NIR, GC and microbial testing.
For more information contact Kathy Bender at 941-342-0007.
# # # |